This company has been marked as potentially delisted and may not be actively trading. NASDAQ:AMDA Amedica (AMDA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisTrendsBuy This Stock About Amedica Stock (NASDAQ:AMDA) Key Stats Today's Range$2.70▼$2.8450-Day Range$0.09▼$2.1952-Week Range$0.18▼$6.40Volume21,443 shsAverage Volume1.07 million shsMarket Capitalization$32.05 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview SINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in 1996 and is headquartered in Salt Lake City, UT. Read More AMDA Stock News HeadlinesMexico Plans 50% Tariff on Chinese Cars Before US, Canada TalksSeptember 10, 2025 | msn.comSINTX Technologies (SINT)September 13, 2024 | es.investing.comSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in 50 years - and it has nothing to do with a single stock. According to multiple Wall Street banks, a coming crisis could keep your portfolio in the red for 10 years or longer. Keith Kaplan, CEO of TradeSmith, is sharing what you can do to protect your wealth before it hits.July 19 at 1:00 AM | TradeSmith (Ad)Here's the Best Way for Investors to Play the IPO MarketNovember 5, 2023 | thestreet.comSilicon nitride ceramics Market 2022 | reach USD 683.74 million by 2028 - GlobeNewswireOctober 7, 2022 | globenewswire.comGlobal Interlaminar Device Market to Witness Growth by a CAGR of ~5% throughout 2022 – 2031 Owing to the - BenzingaMarch 27, 2022 | benzinga.comGlobal 3D Printed Medical Devices Market Report 2021: Market is Projected to Grow from $1.7 Billion in 20 - BenzingaFebruary 9, 2022 | benzinga.comGlobal 3D Printed Medical Devices Market Report 2021: Market is Projected to Grow from $1.7 Billion in 2021 to $4.9 Billion by 2026 - GlobeNewswireFebruary 9, 2022 | globenewswire.comSee More Headlines AMDA Stock Analysis - Frequently Asked Questions How were Amedica's earnings last quarter? Amedica Co. (NASDAQ:AMDA) announced its earnings results on Tuesday, November, 21st. The medical equipment provider reported ($0.93) EPS for the quarter, beating analysts' consensus estimates of ($0.94) by $0.01. The medical equipment provider earned $2.96 million during the quarter. Amedica had a negative net margin of 139.62% and a negative trailing twelve-month return on equity of 148.60%. When did Amedica's stock split? Amedica shares reverse split before market open on Friday, November 10th 2017.The 1-12 reverse split was announced on Friday, November 10th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, November 9th 2017. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. What other stocks do shareholders of Amedica own? Based on aggregate information from My MarketBeat watchlists, some other companies that Amedica investors own include Intrepid Potash (IPI), ParkerVision (PRKR), Anavex Life Sciences (AVXL) and GE Aerospace (GE). Company Calendar Last Earnings11/21/2017Today7/19/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & Medical Instruments Sub-IndustryN/A Current SymbolNASDAQ:AMDA CIK1269026 Webwww.amedica.com Phone(855) 839-3500FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)($3.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$9.32 million Net Margins-139.62% Pretax MarginN/A Return on Equity-148.60% Return on Assets-67.83% Debt Debt-to-Equity RatioN/A Current Ratio1.11 Quick Ratio0.99 Sales & Book Value Annual Sales$11.23 million Price / Sales2.85 Cash FlowN/A Price / Cash FlowN/A Book Value$1.80 per share Price / Book1.50Miscellaneous Outstanding Shares11,870,000Free FloatN/AMarket Cap$32.05 million OptionableNot Optionable Beta-1.24 This page (NASDAQ:AMDA) was last updated on 7/19/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Amedica With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AMDA Stock Alerts